The pathophysiology of ALS includes several metabolic alterations, which may interact with ghrelin signaling, such as loss of appetite [204], as well as neuroinflammation and reactive astrogliosis [205]. This evidence concerns the gene GHRL and amyotrophic lateral sclerosis.